Want to see IDXG full AI Analyst Report?
Interpace Diagnostics Group (IDXG) Financial Statements
Interpace Diagnostics Group Financial Overview
Interpace Diagnostics Group's market cap is currently $33.01M. The company's EPS TTM is $26.89; its P/E ratio is 0.20; Interpace Diagnostics Group has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 38.73M | $ 46.93M | $ 40.21M | $ 31.84M | $ 41.31M |
| Gross Profit | $ 24.13M | $ 29.93M | $ 23.90M | $ 18.23M | $ 17.95M |
| Operating Income | $ 4.08M | $ 8.11M | $ 2.80M | $ -3.84M | $ -11.74M |
| EBITDA | $ 4.76M | $ 8.36M | $ 4.41M | $ -2.27M | $ -1.33M |
| Net Income | $ 24.57M | $ 6.70M | $ 802.00K | $ -5.87M | $ -14.75M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.50M | $ 1.46M | $ 3.50M | $ 4.83M | $ 3.31M |
| Total Assets | $ 33.84M | $ 14.79M | $ 13.02M | $ 15.98M | $ 38.43M |
| Total Debt | $ 1.18M | $ 5.86M | $ 11.19M | $ 16.09M | $ 10.72M |
| Net Debt | $ -1.32M | $ 4.39M | $ 7.69M | $ 11.26M | $ 7.41M |
| Total Liabilities | $ 11.47M | $ 17.01M | $ 28.16M | $ 79.05M | $ 80.84M |
| Stockholders' Equity | $ 22.36M | $ -2.22M | $ -15.14M | $ -63.07M | $ -42.42M |
| Cash Flow | |||||
| Free Cash Flow | $ 5.47M | $ 3.77M | $ 3.32M | $ -8.01M | $ -9.07M |
| Operating Cash Flow | $ 5.83M | $ 4.65M | $ 3.79M | $ -7.69M | $ -8.72M |
| Investing Cash Flow | $ -356.00K | $ -876.00K | $ -87.00K | $ 6.21M | $ -315.00K |
| Financing Cash Flow | $ -4.43M | $ -5.81M | $ -5.03M | $ 3.00M | $ 8.98M |
Currency in USD
